drugset / Trial / NCT00009854

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

NCT00009854

Phase 1/2 Unknown Direct Therapeutics
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of carmustine followed by surgery in treating patients who have recurrent supratentorial malignant glioma or metastatic brain neoplasm.

Timeline

Start
2000-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule Other